IMMUNOCLIN LIMITED

Company Registration Number:
03914021 (England and Wales)

Unaudited micro entity accounts for the year ended 28 February 2025

Period of accounts

Start date: 01 March 2024

End date: 28 February 2025

IMMUNOCLIN LIMITED

Contents of the Financial Statements

for the Period Ended 28 February 2025

Company Information - 3
Balance sheet - 4
Footnotes to the Balance Sheet - 6

IMMUNOCLIN LIMITED

Company Information

for the Period Ended 28 February 2025




Director: Dr Dorothy Helen Bray
Jonathan Leslie Bray
Secretary: Jonathan Leslie Bray
Registered office: 2
Royal College Street
London
NW1 0NH
Company Registration Number: 03914021 (England and Wales)

IMMUNOCLIN LIMITED

Balance sheet

As at 28 February 2025


2025
£

2024
£
Fixed Assets: 40,388 50,486
Current assets: 19,768 85,128
Creditors: amounts falling due within one year: ( 286,520 ) ( 346,006 )
Net current assets (liabilities): ( 266,752 ) ( 260,878 )
Total assets less current liabilities: ( 226,364 ) ( 210,392 )
Total net assets (liabilities): ( 226,364 ) ( 210,392 )
Capital and reserves: ( 226,364 ) ( 210,392 )

IMMUNOCLIN LIMITED

Balance sheet continued

For the year ending 28 February 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions of the small companies regime applicable to micro-entities.

This report was approved by the board of directors on 17 November 2025
And Signed On Behalf Of The Board By:

Name: Dr Dorothy Helen Bray
Status: Director

Name: Jonathan Leslie Bray
Status: Director

The notes form part of these financial statements

IMMUNOCLIN LIMITED

Footnotes to the Financial Statements

for the Period Ended 28 February 2025

  • 1. Employee Information

    Average number of employees: 2

IMMUNOCLIN LIMITED

Footnotes to the Financial Statements

for the Period Ended 28 February 2025

  • 2. Off balance sheet disclosure

    No